REKOO: Rehabilitation Coordinators in Orthopedic Care

Sponsor
Uppsala University (Other)
Overall Status
Completed
CT.gov ID
NCT03944018
Collaborator
(none)
200
1
2
30.8
6.5

Study Details

Study Description

Brief Summary

REKO-O is a study that addressed women and men on sick leave in Uppsala County. Participants which are enrolled in orthopedic care clinic.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Intervention with rehabilitation coordinator
N/A

Detailed Description

REKO-O is a randomized controlled intervention study that addressed women and men on sick leave in Uppsala County. Participants which are enrolled in orthopedic care clinic

Study Design

Study Type:
Interventional
Actual Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Rehabilitation Coordinators in Orthopedic Care
Actual Study Start Date :
Jun 19, 2019
Actual Primary Completion Date :
Jan 12, 2022
Actual Study Completion Date :
Jan 12, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention with rehabilitation coordinator

Intervention with rehabilitation coordinator (RECO)

Behavioral: Intervention with rehabilitation coordinator
Intervention with rehabilitation coordinator in orthopedic care

No Intervention: Control

TAU

Outcome Measures

Primary Outcome Measures

  1. RTW [0.5 year]

    Number of Participants that Return to work (RTW)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 64 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Not recovered in accordance with care plan or cannot be operated and wants an extension of his sick leave
Exclusion Criteria:
  • Obvious medical complications for surgery (wound infection, prosthetic dislocation, stopper or the like)

  • Permanent disability pension

Contacts and Locations

Locations

Site City State Country Postal Code
1 Uppsala university Uppsala Sweden SE-75122

Sponsors and Collaborators

  • Uppsala University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ingrid Anderzen, associate Professor, Uppsala University
ClinicalTrials.gov Identifier:
NCT03944018
Other Study ID Numbers:
  • REKO-O
First Posted:
May 9, 2019
Last Update Posted:
May 24, 2022
Last Verified:
Oct 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ingrid Anderzen, associate Professor, Uppsala University

Study Results

No Results Posted as of May 24, 2022